Vol. 5, Num. 9: Drugmakers costing US $$, 'Right to Try' Bill Approved, Restrictions on Abortion Funding, Gene Therapies, $7M to Fight Ebola Outbreak, VT Passes Drug Import Law, Fix VA Med Records, FDA Approves Migraine Medicine

The James Group Newsletter Vol. 5, Num. 8: Hosp Contrib to High HC Prices, Lifetime limits on Medicaid, $15b Spending Cuts, Drug Plans Drop, MD Insurers Seek Prem Hikes 2019, Walmart Opioid Restrictions, E.Coli, Expand Veteran HC, CVS/Aetna Deal, Price: ObamaCare Indiv Mandate

Vol. 5, Num. 3: Indiana Medicaid, Right To Try Act, Medicare Advantage Hikes, CDC Director Resigns, ObamaCare Fix, Amazon and Healthcare, Do Standing Desks Really Help?

The James Group Newsletter Vol. 5, Num. 7: ACA Insurance Rewritten, CA Aims to Tackle HC Prices, Ryan Leaves Congress, Opioid Crisis, ACA Standing, FDA Restrictions, CVS Improperly Reporting, UHG Forms Army, Boehler As Director, Reinsurance Pools, MegaMerger

Vol. 5, Num. 2: Short-Term Spending Bill, Work-For-Medicaid Rule, ACA Employer Mandate, Government Shutdown, Act to Fight High Drug Prices, Severe Flu Season, Cali Nurses Fight For Single Payer


The James Group Newsletter Vol. 5, Num. 6: Health Premiums Loom, Fed Money for Opioid Crisis, Wellness Tips, $1.3 Trillion Budget, The Omnibus Bill, GOP ObamaCare Fix, KY Abortion Restrictions, TX Medicaid


Vol. 5, Num. 1: New Association Health Plan Rules, Funding for CHIP, Medi-Cal Improvements, 2018 ObamaCare Predictions, Pharmacists Wary of Naloxone Dispersion, New Lifesaving Drugs


The James Group Newsletter Vol. 5, Num. 5: Budget Bill, Penalties for Drug Dealers, Opioid Production Quota, Gun Control, Panel to Review Opioid Crisis, KY Votes to Tax Opioids, ObamaCare at All-Time High, VA Rally Medicaid Growth, Uber/Lyft Ride Share, 2018 Index Figures Changed, VSP $40 Coupon

The James Group Newsletter Vol. 4, Num. 19: Tax Bill "Essentially" Repeal ObamaCare, Reform Bill Repeals Mandate in 2019, Final Approval for Tax Overhaul, No Sweeteners for HSAs, 2 M Children Could Lose Health Coverage

The James Group Newsletter Vol. 5, Num. 4: FDA Tackles High Drug Prices, Focus on Mental Health Over Guns, ObamaCare Market Fix, Idaho Dispute on Health Insurance, Stricter Medicaid Reqs, Flu Vacc Less Effective, Large Medical Bills for OON


Icon FacebookIcon TwitterIcon Mail


Memphis Office
The James Group, LLC
6750 Poplar Avenue
Suite 208
Memphis, TN 38138
Phone: (901) 273-8600
Fax: (901) 273-8700
Atlanta Office
The James Group, LLC 
1100 Circle 75 Parkway SE, Suite 1500
Atlanta, GA 30339
Phone: 770-709-7210
Fax: 901-273-8700
Logo Footer © The James Group. All Rights Reserved.